NCT00301223View on ClinicalTrials.gov

A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

September 30, 2007

Conditions
Neuropathic Pain
Interventions
DRUG

Pregabalin

Trial Locations (7)

Unknown

Pfizer Investigational Site, Beijing

Pfizer Investigational Site, Cheng Du Si Chaun

Pfizer Investigational Site, Guangzhou

Pfizer Investigational Site, Nan Jing, Jiang Su

Pfizer Investigational Site, Qing Dao Shan Dong

Pfizer Investigational Site, Shanghai

Pfizer Investigational Site, Tianjin

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00301223 - A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain | Biotech Hunter | Biotech Hunter